We tested if small conductance, Ca 2 + -sensitive K + channels (SKCa) precondition hearts against ischemia reperfusion (IR) injury by improving mitochondrial (m) bioenergetics, if O2-derived free radicals are required to initiate protection via SKCa channels, and, importantly, if SKCa channels are present in cardiac cell inner mitochondrial membrane (IMM). NADH and FAD, superoxide (O2 − ), and m[Ca 2 + ] were measured in guinea pig isolated hearts by fluorescence spectrophotometry. SKCa and IKCa channel opener DCEBIO (DCEB) was given for 10 min and ended 20 min before IR. Either TBAP, a dismutator of O2 − , NS8593, an antagonist of SKCa isoforms, or other KCa and KATP channel antagonists, were given before DCEB and before ischemia. DCEB treatment resulted in a 2-fold increase in LV pressure on reperfusion and a 2.5 fold decrease in infarct size vs. non-treated hearts associated with reduced O2
− and m[Ca 2 + ], and more normalized NADH and FAD during IR. Only NS8593 and TBAP antagonized protection by DCEB. Localization of SKCa channels to mitochondria and IMM was evidenced by a) identification of purified mSKCa protein by Western blotting, immuno-histochemical staining, confocal microscopy, and immunogold electron microscopy, b) 2-D gel electrophoresis and mass spectroscopy of IMM protein, c) [Ca 2 + ]-dependence of mSKCa channels in planar lipid bilayers, and d) matrix K + influx induced by DCEB and blocked by SKCa antagonist UCL1684. This study shows that 1) SKCa channels are located and functional in IMM, 2) mSKCa channel opening by DCEB leads to protection that is O2 − dependent, and 3) protection by DCEB is evident beginning during ischemia. loading are major factors underlying ischemia and reperfusion (IR) injury. 1 Prophylactic measures targeted in part to mitochondria that reduce cardiac IR injury 2, 3 include ischemic preconditioning (IPC, i.e., brief pulses of ischemia and reperfusion before longer ischemia) and pharmacologic preconditioning (PPC), i.e., cardiac protection elicited some time after the drug is washed out. PPC is theoretically a better approach because it does not require the heart to first undergo brief ischemia. We reported previously that activation of a large (big) conductance Ca 2 + -sensitive K + channel (mBKCa), which may be located in the cardiac myocyte inner mitochondrial membrane (IMM), can induce PPC. 4 The BKCa channel has not been found in the cardiac myocyte plasma membrane, but we have shown that a BKCa channel opener, NS1619, has biphasic effects on mitochondrial respiration, membrane potential (∆Ψm), and superoxide radical (O2 − ) production in isolated mitochondria. 5, 6 This suggested that opening of other mitochondrial K + channels could also elicit PPC. KCa2.3 is one of the known isoforms of SKCa channels that have been identified in endothelial cells; this isoform was found to exert a potent, tonic hyperpolarization that reduced vascular smooth muscle tone. 14 Moreover, there is evidence for the KCa2.2 isoform in rat and human hearts using Western blot analysis and reverse transcription-polymerase chain reaction. 15 Clones of the channel from atria and ventricles showed much greater expression in atria compared to ventricles, and electrophysiological recordings exhibited much greater atrial than ventricular sensitivity to AP repolarization by apamin, a selective SKCa antagonist. 15, 16 We postulated that activation of SKCa channels induces a preconditioning effect similar to that elicited by a BKCa (KCa1.1, maxi-K) opener, and that this effect is mediated via channels located in the IMM, i.e., they promote K + entry into the mitochondrial matrix. We tested if the KCa3.1 (IKCa1) 7,9,17 and KCa2.2 and KCa2.3 (SKCa) 18, 19, 20, 21 opener DCEBIO (DCEB), given transiently before ischemia, elicits PPC in a manner similar to that of the mBKCa channel opener NS1619. 4 We specifically examined the role of DCEB in attenuating the deleterious effects of IR injury on mitochondrial bioenergetics by near continuous measurement of m − to assess the role of SKCa channel opening on O2 − production, presumably by mitochondrial respiratory complexes. We used several approaches to furnish solid evidence for the presence and functionality of SKCa channel proteins in the IMM of guinea pig isolated cardiac mitochondria, and in isolated IMM.
Materials and methods

Isolated heart model
The investigation conformed to the Guide for the Care and Use of Laboratory Animals (NIH Publication 85-23, revised 1996). Guinea pig hearts were isolated and prepared as described in detail 4, 25, 26, 27, 28, 29, 30, 31 with care to minimize IPC. These were pre-oxygenation, maintained respiration after anesthesia with ketamine (50 mg/kg), and immediate aortic perfusion with cold perfusate. Hearts were instrumented with a saline filled balloon and transducer to measure left ventricular pressure (LVP) and an aortic flow probe to measure coronary flow (CF). Heart rate and rhythm were measured via atrial and ventricular electrodes. Hearts were perfused at constant pressure with modified Krebs-Ringer's solution at 37 °C. Heart rate (HR) and rhythm, myocardial function (isovolumetric LVP), coronary flow and venous pO2 were measured continuously. %O2 extraction, myocardial O2 consumption (MVO2) and cardiac efficiency (HR·LVP/MVO2) were calculated. At 120 min reperfusion, hearts not isolated for mitochondria were stained with 2,3,5-triphenyltetrazolium chloride (TTC) and infarct size was determined as a percentage of ventricular heart weight. 4 − where it is converted to the labile cation, 2-hydroxyethidium (2-HE + ), which causes a red-shift in the EM light spectrum. 36, 37 Myocardial fluorescence intensity was recorded in arbitrary fluorescence units (afu) during 35 discrete sampling periods throughout each experiment at a sampling rate of 100 points/s (100 Hz, pulse width 1 μs) during a 12 s triggered period for O2 − and for a 2.5 s triggered period for NADH and FAD, and m[Ca 2 + ]. For each fluorescence study, no drug alone had any effect on background autofluorescence. Signals were digitized and recorded at 200 Hz (Power LAB/16sp, Chart and Scope version 3.6.3. AD Instruments) on G5 Macintosh computers for later analysis using specifically designed programs with MATLAB (MathWorks) and Microsoft Excel software. All variables were averaged over the 2.5 or 12 s sampling period.
Protocol
Hearts were infused with 3 μM DCEBIO (DCEB) for 10 min and ended 20 min before the onset of 30 min global ischemia. DCEB is derived from the benzimidazolone class of compounds, which are known to stimulate chloride secretion in epithelial .
7,8,38 DCEB non-selectively opens KCa2.2 and 2.3 channels. 7, 18, 19, 20, 21 In most hearts DCEB was bracketed either with 40 μM PAX (paxilline), a blocker of BKCa channels, 39 20 μM TBAP, a chemical dismutator of O2 − that can enter the matrix, 200 μM GLIB (glibenclamide), a KATP channel blocker, or 100 nM TRAM (TRAM-34), an established blocker of IKCa conductance channels.
9 TRAM was selected because DCEB also opens IKCa channels. 7,9,17,21 PAX, TBAP, GLIB, or TRAM was given 5 min before, during DCEB perfusion, and for 5 min after stopping DCEB. In a separate study DCEB was bracketed with 10 μM NS8593, a specific antagonist of SKCa channels 22,23 to compare with a no drug IR control. Drug exposure was discontinued 15 min before the onset of global ischemia that lasted for 120 min. NS8593 caused a transient fall in systolic (and developed) LVP and an increase in coronary flow. Additional studies (not displayed) showed that each of these drugs, except for NS8593, given alone (without DCEB) for 20 min before ischemia elicited no appreciable effects and had no different effect on IR injury than the drug-free controls.
Statistical analyses
A total of 155 isolated heart experiments were divided into 7 groups, a drug-free control, and DCEB alone or plus NS8593, PAX, TBAP, GLIB or TRAM. Mitochondria were freshly isolated from 25 guinea pig hearts by differential centrifugation as described previously. 5, 6, 34, 40, 41 To test mitochondrial viability and function in each preparation, the respiratory control index (RCI, state 3/state 4) was determined under both pyruvate (P, 10 mM), and succinate (S, 10 mM) + rotenone (R, 4 μM) conditions. State 3 respiration was determined after adding 250 μM ADP. Intact mitochondrial preparations were discarded if the RCI was less than 3 with succinate + R or less than 9 with pyruvate.
To isolate fraction-enriched IMMs, isolated mitochondria were shocked osmotically by incubating in 10 mM phosphate buffer saline (PBS) (pH 7.4) for 20 min, and then in 20% sucrose for another 15 min. The IMMs were sonicated for 30 s, 3 times, and then centrifuged at 8000 g for 10 min. The supernatant containing sub-mitochondrial particles was fractionated using a continuous sucrose gradient (30% to 60%) and centrifuged at 80,000 g overnight in a SW28 rotor. The IMMs (enriched in the heavy fractions) were suspended with the isolation medium without EGTA and centrifuged at 184,000 g for 30 min. The final pellet enriched IMMs were suspended in isolation medium without EGTA and BSA and stored at − 80 °C in small aliquots until use.
Enhancement of calmodulin-binding proteins from IMM
Calmodulin binds to SKCa channels so the calmodulin binding proteins obtained from the IMMs were concentrated to enhance the sensitivity of detection of mSKCa channels by Western blotting and by mass spectrometry. For calmodulin column chromatography (calmodulin-sepharose beads) the IMMs (5 mg protein) were solubilized for 2 h at 4 °C in washing buffer, 200 mM KCl, 1 mM MgCl2, 200 μM CaCl2, 20 mM HEPES, pH 7.4, and 0.5% CHAPS with protease inhibitors. After centrifugation at 50,000 g for 30 min, the supernatant was applied to a calmodulin-sepharose column (10 by 1.5 cm) pre-equilibrated with the solubilization buffer containing 0.1% CHAPS. The column was washed rapidly with 500 mL of washing buffer as above. The proteins were eluted from the column by 2 mM EGTA in the elution buffer (200 mM KCl, 20 mM HEPES, pH 7.4, 0.1% (w/v) CHAPS) after washing. The fractions collected were concentrated and the proteins were separated by 2-D gel electrophoresis as follows.
Purification of SKCa channel proteins from IMM by isoelectric focusing
After isolating the IMM protein fraction (Sections 2.5 and 2.6) the first dimension of isoelectric focusing (IEF) during 2-D gel electrophoresis was done in native gel buffer on an Immobilon Drystrips (Amersham) with pH 4-7 gradient. The antibody was targeted to KCa2.3 (a.k.a. hSK3, KCN3, Osenses Pty, Ltd.). The second dimension was done in a 10% Criterion® tris-SDS gel (Bio-Rad). Two identical gels were run at the same time, with one used for transfer to nitrocellulose membrane for Western blot analysis, and the other for silver staining and visualization.
IMM protein identification using electrospray LC/MS
IMM proteins (from Sections 2.5 and 2.6) were digested with trypsin and subjected to pH focusing into 10 fractions over pH 3-10 and each fraction was directly analyzed using a NP LC/ESI mass spectrometer (Finnigan™ LTQ™ Ion Trap MS, Thermo Electron Corporation) to generate specific mass spectra typical for a given protein. The instrument utilizes stepped normalized collision energy (SNCE) to improve fragmentation efficiency over a wide mass range. This increases the capacity of a linear trap and the accuracy and sensitivity of peptide detection in the fmol range. A mass database (NCBI Entrez Pubmed protein) was searched for matching proteins and consequently the SKCa channel protein of interest was tentatively identified in IMM.
Purification of intact mitochondria by Percoll gradient fractionation
To further verify localization of SKCa channel protein in an intact mitochondria preparation, the Percoll gradient technique, 42, 43 with slight modifications, was used to purify intact mitochondria and immunohistochemical staining was utilized to identify SKCa channel protein. In brief, mitochondria isolated as previously described 5,6,34,40,41 were layered over 30% Percoll (in buffer A containing 450 mM mannitol, 50 mM HEPES, 2 mM EDTA, pH adjusted to 7.4 followed by addition of 50 mg BSA), and centrifuged at 95,000 g for 30 min. The lower dense band observed at the bottom of the tube, enriched in mitochondria, was collected using a long tip glass pipette. Collected mitochondria (~ 4 mL) were resuspended in the same buffer used to dilute Percoll, and centrifuged again at 6300 g. The resulting pellet was suspended in the same buffer without BSA (buffer B) and re-centrifuged at 6300 g. The mitochondrial pellet was resuspended in a small volume (~ 0.3 mL) of buffer B and stored until further use.
Identification and localization of SKCa channel protein in purified mitochondria
Immuno-histochemical staining with an anti-SKCa antibody and confocal microscopy were used, in part, to verify that SKCa channel protein resides in mitochondria. Briefly, mitochondria, isolated and purified as described above (Section 2.9), were fixed onto poly-lysine coated coverslips. Mitochondrial structures were then fixed using paraformaldehyde and membranes were permeabilized using Triton X-100 and non-specific binding sites blocked by goat serum albumin. Coverslips were then incubated in solution containing anti-KCa2.2 (anti-SK2, ETQMENYDKHVTYNAERS, Alomone Labs (1:1000 in 5% milk)) and anti-ANT (adenine nucleotide translocase, Invitrogen) antibodies for 30 min followed by three washes in 0.1 M PBS. Coverslips were then incubated in appropriate secondary antibodies (Alexa Flour 455 and 546 respectively, Invitrogen (1:3000 in 2% milk)) for another 30 min and were then transferred onto microscope slides and visualized using a Leica confocal microscope (TCS SP5). Alternatively, mitochondria were utilized for immuno-gold labeling to localize SKCa channel protein in individual mitochondria.
Localization of SKCa channel protein by immuno-gold labeling and electron microscopy
Immuno-electron microscopy (IEM) was used to localize SKCa protein in purified cardiac mitochondria similar to the technique used by Douglas et al. 44 to localize BKCa channel protein in mitochondria. The final mitochondrial pellet, prepared as described above (Section 2.9), was resuspended in 500 μL isolation buffer before centrifugation at 16,000 g for 20 min. The supernatant was discarded and an EM fixative containing 0.1% glutaraldehyde + 2% paraformaldehyde in 0.1 M NaH2PO4 buffer (pH 7.4) was added. After 1 h fixation at room temperature the pellet was gently detached from the tube with a 25 G needle and processed following the protocols of Berryman and Rodewald. 45 Pellets were washed 3 × 20 min in 0.1 M NaH2PO4 buffer containing 3.5% sucrose and 0.5 mM CaCl2, then rinsed in 0.1 M glycine in NaH2PO4 buffer for 1 h on ice before returning to NaH2PO4 buffer. The pellets were cut into 1 mm cubes and then washed 4 × 15 min in 0.1 M tris maleate buffer + 3.5% sucrose, pH 6.5, at 4 °C followed by post fixation in 2% Uranyl acetate (w/v) in tris buffer, pH 6, for 2 h at 4 °C; specimens were then given a final rinse 2 × 5 min in Tris maleate buffer, pH 6.5. The specimens were then processed by the progressive lowering-of-temperature method into Lowicryl K4M resin and the resin was polymerized by UV irradiation. Ultrathin sections (70 nm) were cut onto Formvar/carbon coated grids. Immunolabeling was performed by floating grids on droplets of 0.1 M NaH2PO4 buffer containing 5% BSA (PB-BSA), then incubating with rabbit polyclonal anti-KCa2.2 (anti-SK2, Alomone Labs) diluted 1:50 for 90 min, or with the positive control mitochondrial marker, cytochrome c oxidase (anti-COX1: Complex IV, subunit 1) mouse monoclonal antibody diluted 1:500. Non-immune rabbit polyclonal serum was used as the negative control. This step was followed by 3 × 5 min washes in PB-BSA. The sections were then incubated with goat anti-rabbit IgG, or goat anti-mouse IgG, conjugated to 10 nM colloidal gold 46 for 90 min at room temperature, rinsed in distilled water, and then stained with 2% aqueous uranyl acetate. Sections were examined in a JEOL JEM2100 TEM at 80 kV.
Purification/identification of SKCa channel protein by isoelectric focusing (IEF) and Western blotting
Total mitochondrial protein, once isolated and purified as above (Section 2.9), was partitioned by IEF and the resulting fractions were analyzed for mSKCa protein. Mitochondria (1 mg) were suspended in 3 mL electrophoresis buffer (0.1% w/v CHAPS, 0.1% w/v dodecyl maltoside, 5% (v/v) glycerol, 10 mg dithiothreitol) and IEF was performed using the Micro-Rotofor system (BioRad, CA) for 4 h at 400 mA constant current. The fractions thus obtained were collected and analyzed for SKCa protein by Western blot using the anti-KCa2.2 (anti-SK2) antibody. Briefly, equal volumes of the 10 fractions obtained by IEF were suspended in Laemmli buffer and resolved using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), 47 as originally described by Laemmli, 48 and transferred onto poly vinylidene difluoride membranes using Transblot System (Bio-Rad) in 50 mM tricine and 7.5 mM imidazole transfer buffer. Membranes were blocked with 10% non fat dry milk in tris buffered saline-TBSt (25 mM Tris-HCl at pH 7.5, 50 mM NaCl and 0.1% Tween 20) by incubating for 1 h followed by incubation in the antiKCa2.2 antibody (anti-SK2) solution overnight at 4 °C. After three washes with TBSt the membrane was incubated with an appropriate secondary antibody conjugated to horseradish peroxidase for 3 h. After five washes with TBSt the membrane was incubated in enhanced chemiluminescence detection solution (ECL-Plus, GE-Amersham) and exposed to X-ray film for autoradiography. The protein fraction containing the largest amount of SKCa was used for single channel recordings.
Enriching and incorporating mSKCa channel protein into lipid bilayers
Channel activity of the purified and enriched mSKCa protein was monitored by incorporating it into a planar lipid bilayer, as previously described. 49 Briefly, phospholipids were prepared by mixing phosphatidyl-ethanolamine, phosphatidyl-serine, phosphatidyl-choline, and cardiolipin (Avanti Polar Lipids) in a ratio of 5:4:1:0.3 (v/v). The phospholipids were dried under N2 and re-suspended in n-decane to a final concentration of 25 mg/mL. The cis/trans chambers contained symmetrical solutions of 10 mM HEPES, 200 mM KCl and 100 μM CaCl2 at pH 7.4. The cis chamber was held at virtual ground and the trans chamber was held at the command voltages. SKCa protein was added into the cis chamber. The effect of the SKCa blocker apamin, 100 nM, on channel activity was tested by adding it to the cis chamber in the presence of 100 μM CaCl2. To test for Ca 2 + dependence of the SKCa channel, [Ca 2 + ] was serially increased (1, 50 and 100 μM) in the cis chamber. Currents were sampled at 5 kHz and low pass filtered at 1 kHz using a voltage clamp amplifier (Axopatch 200B, Molecular Devices) connected to a digitizer (DigiData 1440, Molecular Devices), and recorded in 1 min segments. The pClamp software (version 10, Molecular Devices) was used for data acquisition and analysis. Additional analyses were conducted using Origin 7.0 (OriginLab).
Matrix K + measured in isolated mitochondria
Cardiac isolated mitochondria (0.5 mg protein/mL) were suspended in respiration buffer containing 130 mM KCl, 5 mM K2HPO4, 20 mM MOPS, 2.5 mM EGTA, 1 μM Na4P2O7, 0.1% BSA, pH 7.15 adjusted with KOH. Buffer [Ca 2 + ] was less than 100 nM as assessed by the fluorescence dye indo 1. Matrix K + was monitored during state 4 respiration (200 μM ATP) with substrate Na-pyruvate (10 mM) in a cuvettebased spectrophotometer (QM-8, Photon Technology International, PTI) with light (λex 340 and 380 nm; λex 500 nm) in the presence of the fluorescence dye PBFI (1 μM per mg/mL protein, Invitrogen) [50] . PBFI, in the acetylated methyl-ester (AM) form, was added to the mitochondrial preparation and incubated at 25 °C for 20 min. After entering the matrix PBFI is retained in the matrix after it is cleaved from the methyl-ester. During the last pellet wash the extra-matrix residual dye was washed out. Most experiments were conducted in the presence of 500 μM quinine to block the mitochondrial K + /H + exchanger (mKHE) and extrusion of the K + . 50 In some experiments 0.25 nM valinomycin, a K + ionophore, was given to verify an increase in matrix K + influx, and to be used as a reference for the change of K + influx by DECB ± its antagonist UCL1684.
Results
DCEB protects isolated heart against IR injury
Spontaneous heart rate averaged 242 ± 13 beats/min before ischemia for all groups; this was not statistically different at 120 min reperfusion for all groups (data not displayed). If ventricular fibrillation (VF) occurred, it was only once within the first 5 min of reperfusion in any heart; all were converted to sinus rhythm with intracoronary lidocaine. After 5 min reperfusion all hearts remained in sinus rhythm, some with occasional pre-ventricular excitations. In data not displayed the incidence of VF on reperfusion was CONTROL 100%, DCEB + TBAP 100%, DCEB 76%, DCEB + TRAM 72%, DCEB + PAX 77%, and DCEB + GLIB 77% (all nonsignificant vs. control group). Fig. 1, Fig. 2, Fig. 3, Fig. 4 show the marked degree of dysfunction or damage in the untreated control group during and after global ischemia and the beneficial effects of PPC elicited by DCEB treatment before ischemia. Developed LVP (Fig. 1A ) and coronary flow (Fig. 1B) were reduced in each group after ischemia compared to before ischemia, but these changes were much larger in the CONTROL and DCEB + TBAP groups than in the other groups. Similarly, cardiac efficiency ( Fig. 2A ) was lower and infarct size (Fig. 2B) was largest in the CONTROL and DCEB + TBAP groups than in all other groups. The drug treatments before ischemia had no effects by themselves on any of the functional variables. These figures indicate that these variables were markedly improved on reperfusion after treatment with DCEB and that these improvements were reversed by TBAP, but not by PAX, TRAM, or GLIB. There was no detectable change in NADH and FAD autofluorescence in any group by drugs given and terminated before ischemia (Fig. 3A,B) . NADH (Fig. 3A ) remained higher at the end of ischemia and fell less during reperfusion after treatment with DCEB; this was reversed by TBAP but not by TRAM. FAD remained lower at the end of ischemia and rose less during reperfusion after treatment with DCEB (Fig.  3B) ; this was reversed by TBAP, but not by TRAM. In other experiments there was no detectable change in NADH or FAD on reperfusion after DCEB + PAX or + GLIB treatment vs. DCEB alone.
DHE fluorescence (O2 − formation) (Fig. 4A) In companion experiments (Fig. 5A-D ) the protective effects of DCEB were abolished or antagonized by the SKCa channel antagonist NS8593, thus demonstrating that DCEB protected via activation of SKCa channels. DCEB-induced maintenance of developed LVP was completely blocked, while the maintenance of coronary flow and the reduction of diastolic LVP and FAD oxidation by DCEB were all markedly reversed by NS8593. NS8593 alone significantly depressed developed LVP when given before ischemia and tended (non significantly) to slightly increase coronary flow, possibly indirectly due to reduced ventricular compression; thus the small increase in flow (Fig. 5B ) noted in the presence of DCEB is likely due to NS8593 rather than to DCEB per se. Generally, cardiac depression before ischemia is cardioprotective, but giving NS8593 with DCEB before ischemia, resulted in a worsening of contractile function on reperfusion. These studies demonstrated that DCEB had protective effects against cardiac IR injury mediated by the SKCa channel, and that cardiac mitochondria appeared to be involved in mediating this protection. Studies were then undertaken to isolate and identify the target of DCEB, the SKCa protein, in cardiac isolated mitochondria and in IMM, and to verify the functionality of the protein in an artificial lipid bilayer.
Isoelectric focusing and peptide sequences identify SKCa in isolated IMM
IMM protein, enhanced for calmodulin-binding residues, was separated by 2-D electrophoresis after silver staining. Three peptide spots of approximately 70 kDa at pH 5.2-5.5 were detected as SKCa using the anti KCa2.3 (anti-hSK3) (Fig. 6, panels A-C) . Complementing this finding, a KCa2.3 protein was identified by ESI-mass spectrometry from five matching peptides with an amino acid coverage of 10.73% (Table 1 ). There was no evidence for peptides matching Na + /K + ATPase or Ca 2 + ATPase suggesting the absence of sarcolemmal and t-tubular membranes in the mitochondrial fraction. The mass spectrum of one of these peptide sequences is shown (Fig. 7) . These results demonstrated that SKCa channels were present in the IMM. Letters in bold represent those peptides identified based on their MS/MS profiles. The list below the sequence represents all peptides identified by mass spectrometry. The gray-filled sections of the bar above the sequence represent the position of the identified peptides in the sequence. Also shown is the molecular weight and pI of the protein. There are 4 peptides covering 10.89% of the total amino acids of this protein segment. Note that the mass spectral analysis showed a 70% amino acid coverage in the calmodulin binding domain (CaMBD), a peptide sequence just before (N terminus) the pore forming subunit 1, and the entire sequence of subunit 6. Table 1 .
Western blots of serially purified mitochondria demonstrate SKCa channel protein
Mitochondria exhibited increasing band densities for both SKCa and ANT protein (Fig. 8) when enriched by Percoll gradient serial purification. This furnished compelling Western blot evidence that SKCa channel protein increases in abundance with ANT, which is present only in the IMM. 
Immunochemistry and confocal microscopy identify SKCa channel protein in mitochondria
Confocal microscopy was used to localize SKCa protein to intact mitochondria. Cardiac mitochondria were visualized as stained by an antibody against ANT (green), and SKCa channel protein was visualized using the anti-KCa2.2 (anti-SK2) antibody (red) (Fig. 9) . Overlay of the two images (yellow) shows colocalization of SKCa and ANT proteins in cardiac mitochondria. Since ANT localizes only to the IMM, this suggested that SKCa channel protein also localizes to the IMM. Fig. 9 . SKCa protein identified in isolated mitochondria and visualized by confocal microscopy. Overlay of the two images (anti-ANT, green and anti-SKCa, red) demonstrates co-localization (yellow) of the SKCa protein in mitochondria.
Immuno-gold labeling and EM show localization of SKCa channels in mitochondrial matrix
To further confirm the presence and localization of the SKCa channels on the IMM, mitochondria were visualized at high resolution using IEM. A large field EM view shows largely normal appearing cardiac mitochondria with intact outer membranes and cristae (Fig. 10) . Enhanced resolution of immuno-gold labeled mitochondria shows gold particles attributed to SKCa channels (Fig. 11A,B) or cytochrome c oxidase (COX) (Fig. 11C) within the matrix; in detailed examination of electron micrographs approximately 50% contained at least 2 gold particles. Negative controls (Fig. 11D ) (non-immune rabbit polyclonal serum) showed no gold particles in any field. Fig. 8, Fig. 9, Fig. 11 confirm that SKCa channels are located in mitochondria and most likely in the IMM. . Immuno-electron microscopy of isolated cardiac mitochondria. A, B: SKCa protein as visualized in two mitochondria; 50% of all viewed mitochondria exhibited gold labeling. Gold labeling was obtained by immuno-gold secondary antibody conjugated to primary rabbit polyclonal anti-KCa2.2 (anti-SK2). C: Positive control was anticytochrome c oxidase (COX1) conjugated to goat anti-rabbit or mouse conjugated to colloidal gold; each mitochondrion in a large field view exhibited at least two gold particles. D: Negative control was only secondary polyclonal rabbit antibody conjugated to gold; there was no gold labeling of any mitochondria in any views.
Mitochondrial SKCa protein forms a functional channel
To test if purified mitochondrial SKCa protein forms a functional channel, SKCa protein, isolated as noted above (Section 2.9), was incorporated into a planar lipid bilayer for electrophysiological measurements. In the lipid bilayer, the SKCa protein exhibited robust activity in the presence of 100 μM [Ca 2 + ] (Fig. 12A) . Two conducting states with chord conductances of 230 and 730 pS were observed when recorded in an ionic condition of equimolar 200 mM KCl. Adding apamin blocked the channel activity (Fig. 12B) indicating that the functional channel formed by the mSKCa protein was inhibited by this SKCa channel blocker. The mSKCa channel protein incorporated into the planar lipid bilayer also displayed Ca 2 + -dependent activity (Fig. 13) (Fig. 13, inset) . 
DCEB-induced increased matrix [K + ] is blocked by UCL1684
The consequence of opening of SKCa channels to changes in mitochondrial matrix [K + ] was also determined. In isolated mitochondria the SKCa channel opener DCEB increased matrix [K + ] in the presence of quinine to inhibit KHE and thus counter K + extrusion (Fig. 14A,B) . The observed influx of K + into the matrix was confirmed by similar K + influx induced by the K + ionophore valinomycin. The effect of DCEB was blocked by UCL1684 (an SKCa blocker) but not by iberiotoxin (IBX) (a blocker of BKCa but not SKCa channels) (Fig. 14B) . The increase in matrix K + uptake induced by DCEB and blocked by UCL1684 (Fig. 14) , and the Ca 2 + induced increases in K + current and inhibition by apamin in lipid bilayers (Fig. 12,  Fig. 13 ) functionally linked DCEB's cardiac effects to SKCa channel presence and activity in cardiac mitochondria. 
Discussion
Our results suggest a novel role for the SKCa channel in cardiac myocyte preconditioning, likely mediated via altered mitochondrial function due to opening of SKCa channels located in myocyte mitochondrial IMM (mSKCa). Our comprehensive experimental approach shows that the well-known SKCa (and IKCa) channel activator DCEB preconditioned hearts and that this was fully reversible by bracketing DCEB with the intra-matrix O2 − dismutator TBAP. Cardioprotective effects of DCEB were attributed specifically to activation of SKCa channels and not to activation of KATP, IKCa, or BKCa channels because NS8593, but not GLIB, TRAM, or PAX blocked its effects. DCEB increased K + flux in isolated mitochondria and the purified SKCa protein formed a functional channel when incorporated into lipid bilayers. Thus mSKCa channel opening, similar to that of mKATP and mBKCa channel opening, appears to induce PPC by an as yet unclear mechanism related to enhanced matrix K + entry. Moreover, mitochondrial-derived O2 − is required to initiate PPC by DCEB, because if O2
− is rapidly converted to downstream products the protection by DCEB is lost.
Just as we supported our evidence that the SKCa channel is specifically involved in PPC of isolated hearts, we sought to support specifically that the mSKCa channel was associated with cardioprotection. To provide evidence that DCEB has protective effects mediated by mSKCa channels, it was necessary to rigorously identify mSKCa protein in purified mitochondria, and specifically in the IMM. To do so we utilized Western analysis and immuno-histochemistry, confocal microscopy, electron microscopy, and mass spectrometry of purified mitochondrial proteins derived from IMM. Organelle location was accompanied by channel functionality in isolated mitochondria and in lipid bilayers, thus supporting that this channel may play a role in cardiac protection via a mitochondrial mechanism. Overall our study indicates that the SKCa channel, localized in the cardiac cell IMM, mediates the effect of DCEB in preconditioning of the heart via a mitochondrial mechanism related to mK + flux and O2 − generation.
The dequalinium analogue, UCL1684, is known to block opening of apamin-sensitive SKCa channels in mammalian cell lines. 51 We support involvement of the mitochondrion in DCEB's PPC effect because TBAP could block the protective functional effects of DCEB as well as block DCEB's effect to decrease ischemia-induced levels of mCa 2 + and of O2 − , presumably generated by complexes along the electron transport system. 52 Also, DCEB directly induced an increase in matrix K + uptake. Moreover, since DCEB had no significant effects on coronary flow (Fig. 1) , automaticity, or contractility, this suggests DCEB had no effect on endothelial/vascular or ventricular cell function. Overall, our results demonstrate the marked cardioprotective effects after preconditioning with DCEB and implicate mSKCa channel opening and generation of O2 − , or its products, as initiators and inhibitors of mitochondrial as well as cardiac myocyte PPC.
The improvement in cardiac function by DCEB was accompanied by reduced formation of O2 − , reduced m[Ca 2 + ], and improved redox state (more normal NADH and FAD levels) during both ischemia and reperfusion. These cardioprotective effects of DCEB were blocked only by either TBAP or NS8593. We suggest that initial formation of O2
− is essential for the triggering mechanism of PPC by mSKCa channel activation. However, a downstream product of O2
− , e.g. H2O2, might actually mediate the protective effects of DCEB. A similar dependence for O2 − has been observed for the mKATP channel opener diazoxide, 24 the BKCa channel opener NS1619, 4 and volatile anesthetics. 27,34 Drug lipophilicity with mitochondrial membrane penetration may be an important common denominator for the activity of drugs such as diazoxide, a putative mKATP channel agonist, and DCEB. The cell membranes of vascular smooth muscle, neural, and secretory cells contain large conductance (200-300 pS) i.e. big Ca 2 + -sensitive K + (BKCa, aka maxi-KCa) channels that when opened produce vasodilation, hyperpolarization, and secretion. BKCa channel opening is activated by increased [Ca 2 + ]i and by cell membrane depolarization. 53 Activation of BKCa over a range of [Ca 2 + ] is mediated at several binding sites within the channel 54 so that there is a wide range of [Ca 2 + ] responsiveness (Ka 10-1000 μM). 55 As K + exits the cell with BKCa channel opening, this elicits cell membrane repolarization or hyperpolarization, which in turn reduces Ca 2 + entry by closing voltage-dependent Ca 2 + channels. Altered redox potential in smooth muscle 56 suggested mitochondrial involvement. Xu et al. 57 first furnished evidence that BKCa channels are located in cardiac mitochondria.
Distribution and function of Ca
The membrane bound, but non-voltage-gated, KCa channels, i.e., SKCa and IKCa 11 are gated by Ca 2 + and other factors. SKCa (a.k.a. KCa2.1-2.3, KCNN1-3-gene symbol) channels have characteristics that largely differ from the BKCa channels i.e. small unitary conductance (10-30 pS), voltage independence with activation only by Ca 2 + at very low Ka (0.3 μM with steep I/V slopes), a sensitivity to apamin, heteromeric assembly of the SKCa pore forming subunits with calmodulin (CaM), N rather than C terminal EF hand domain for Ca 2 + binding, and Ca 2 + gating near the K + selectivity filter. 58 SKCas are unique in that calmodulin forms an integral part of the channel, forming its Ca 2 + -sensitive subunits. 59 In the presence of Ca 2 + , two calmodulin binding domains form a dimer, which allows the channel to open.
12
Antibodies against KCa2.2 and KCa2.3 were both used for immuno-staining and Western blot characterizations in purified mitochondria and in the enriched IMM fraction, respectively. We found that the identified protein was positive to both sets of antibodies. Because the sequence homology of the SKCa family of channels (KCa2.1, KCa2.2, KCa2.3) is highly conserved, 60 the commercial antibodies we used might not have been selective enough to definitely identify the molecular identity of the specific mSKCa isoform. But we did confirm that the purified mSKCa protein formed a functional channel by recording channel activity after incorporating the protein into a planar lipid bilayer. The channel was inhibited by apamin, a blocker of plasmalemmal membrane SKCa channels. However, the recorded conductance states were higher than those reported for cell membrane SKCa channels, which are in the range of 10-14 pS.
11, 58 The underlying cause of this discrepancy is unclear. It is possible that mSKCa channels have biophysical attributes that are different from their cell membrane counterparts. In particular, the mSKCa channels exhibited multiple conducting states that appear to be Ca 2 + -dependent. As the [Ca 2 + ] increased, the channel's conductance also increased. Thus, at very low [Ca 2 + ], lower conductances may be revealed that are closer to those reported for the plasmalemmal SKCa channel. In support of this, in some recordings we infrequently observed a conductance of 70 pS at 1 μM [Ca 2 + ]. However, the mechanism that underlies this Ca 2 + -dependent gating of the mSKCa channel has yet to be delineated. Though it is premature to speculate on the structural homology between the mitochondrial and plasmalemmal SKCa channels, based on our MS data and the Ca 2 + sensitivity of the mSKCa channel, the Ca 2 + calmodulin-binding domain and the S6 transmembrane region appear to be conserved. Indeed, the block of channel activity by apamin showed that this mSKCa channel does share a pharmacological property similar to the plasmalemmal SKCa.
However, the planar lipid bilayer experiments appear to indicate that the apamin binding site and the Ca 2 + binding site are both localized to the same side of the mSKCa channel. This was an unexpected finding because apamin has been reported to be an external pore blocker that binds to the outer pore region of the plasmalemmal SKCa channel, 61 whereas the Ca 2 + sensing region was believed to be on the intracellular side, conferred by calmodulin that is constitutively bound to the C-terminus of the channel.
12 Consequently, our findings would imply that the position of the C-terminus in the mSKCa channel differs from that in the plasmalemmal SKCa channel. Therefore, based on the sidedness of the apamin effect and Ca 2 + sensitivity, together with our observed biophysical properties, the mSKCa channel may exhibit some functional and structural differences from the plamalemmal SKCa channel. Additional experiments will be needed to confirm this possibility.
Our study represents the first conclusive report that identifies SKCa channels in cardiac myocyte mitochondria. Their presence in the IMM would indicate that they have an important function in finetuning regulation of mitochondrial bioenergetics, perhaps via volume control, which is largely controlled by K + flux. 62 Crystal structures show that SKCa + CaMBD contains two EF hand motifs within each of the globular N and C terminal regions separated by a flexible linker. 62 The C terminus is required to establish the link of SKCa and CaM. Substitution of neutral amino acids for aspartate and glutamate only in N terminus EF hand region blocks Ca 2 + gating. This binding site is positioned just below the K + selectivity filter, which suggests that conformational changes near or even in the selectivity filter itself function to gate SKCa channels. The 18 amino acid bee venom toxin apamin is highly selective for SK2 by docking at the pore entrance and between the S3 and S4 loops. 63 SKCa channels in neurons lie adjacent to Ca 2 + stores and Ca 2 + channels. In nerve cells SKCa channels play a role in setting the intrinsic firing frequency, while BKCa channels regulate action potential shape and may contribute to the unique climbing fiber response. 15 The K + flux mediated by BKCa and SKCa channels in mitochondria may be differentiated by both their sensitivities to Ca 2 + and dependence on ΔΨm during states 3 and 4 respiration. Because there are many differences between these channels, the functional effects of opening these channels are expected to differ; e.g., unlike BKCa, SKCa channel opening may "fine tune" matrix K + influx due to changing Ca 2 + levels independent of changes in ΔΨm during the variable rate of oxidative phosphorylation.
mSKCa channel opening triggers preconditioning via ROS
The presence of both SKCa and BKCa channels in cardiac myocyte IMM indicates a functional importance for these channels during excess mCa 2 + loading; moreover their endogenous opening during IPC, or as a pharmacological therapy, may be an important trigger for cardioprotection. It is unclear if these drugs actually open these K + channels directly to elicit preconditioning, or if they themselves alter mitochondrial bioenergetics (as mild uncouplers of oxidative phosphorylation), which mediates the memory of preconditioning by other downstream effectors. Although the mitochondrial preconditioning effect of DCEB appears to require both mSKCa channel opening and generation of O2 − , these factors are not effectors of PPC as the DCEB and TBAP are washed out before ischemia.
There is ample evidence that O2
− is necessary to trigger PPC by mK + channel openers but the mechanism of O2 − , and its products or reactants, in mediating PPC is unknown. An increase in redox state (increased NADH, decreased FAD) at a given [O2] can result in increased O2 − generation. 64 O2 derived free radical "bursts" are known to occur during reperfusion when excess O2 is available. Our group 4, 26, 27, 33 and others 35, 65 have shown, moreover, that ROS are also formed in excess during ischemia before reperfusion when tissue O2 tension decreases, the redox state increases and then decreases, and cytochrome c oxidase (complex IV) activity is low. 66 The putative mKATP channel opener diazoxide 67 mimicked IPC on reducing infarct size and the ROS scavengers, N-acetylcysteine 68 or N-mercaptopropionyl-glycine, 24 blocked the preconditioning effect of diazoxide. It has been suggested that mKATP channel opening can cause a small increase in ROS formation, 69 which may trigger cardioprotection through activation of protein kinases. Conversely, ROS have also been proposed to activate the sarcolemmal KATP channel by modulating its ATP binding sites as this effect is blocked by GLIB or by ROS scavengers. 70 Others have proffered that ROS produced during IPC may afford cardioprotection on reperfusion directly, or via a feed forward mechanism for KATP channel-induced ROS production. 71, 72 In the present study evidence that the protective effect of DCEB is mediated by ROS is indicated by reversal of the protection in the presence of TBAP. O2 − or OH , or even non-radical reactants like H2O2 or ONOO − (formed in the absence or presence of NO , respectively) may actually produce the preconditioning responses, but O2
− appears necessary to initiate the response. It is also possible that mSKCa, mBKCa, and or mKATP channel activation is altered by ROS as a feed forward controller of mitochondrial function. Enhanced electron transfer before ischemia may minimize respiratory inefficiency, i.e., reduced matrix contraction and improved respiration on reperfusion. mSKCa channel opening, like mKATP channel opening, and indeed opening of any mK + channel, could induce PPC by mildly enhancing O2
− generation, which stimulates enzymatic pathways that help to protect the cell from IR injury. Interestingly, we observed that O2 − dismutation by TBAP blocked protection by DCEB.
When DCEB was given alone or with any of the inhibitors, it had no direct detectable effect on mechanical function or mitochondrial bioenergetics (redox state, O2 − levels) in isolated hearts. In our related study 4 neither NS1619 nor its antagonist PAX showed any direct effect on measured variables. In the ex vivo, intact heart perfused with adequate substrates and O2, mitochondria are mostly respiring in the non-resting state 3, so small changes in O2 − between states 3 (ample ADP) and 4 (consumed ADP) respiration cannot be observed. However, in isolated cardiac mitochondria we reported that low, but not high, concentrations of the BKCa channel opener NS1619 can increase resting state 4 respiration and ROS generation while maintaining IMM potential (∆Ψm). 6 We propose similarly that DCEB, like NS1619, increases intramatrix K + , which is replaced immediately with H + via KHE. We suggest that at low concentrations of these openers a transient increase in matrix acidity, i.e., via a proton leak, stimulates respiration but maintains ΔΨm so that a greater amount of O2 − is generated at mitochondrial respiratory complexes due to impaired electron transport. O2
− itself, or a reactant, may in turn stimulate downstream-induced phosphorylation pathways fostering K + channel opening as necessary when ischemia occurs. The net effect could be preservation of mitochondrial bioenergetics during ischemia as evidenced by better maintenance of the reduced state (high NADH and low FAD) and smaller increases in O2
− generation and less m[Ca 2 + ] overload. This could lead to better preservation of oxidative phosphorylation and ATP turnover leading to better utilization of ATP on initial reperfusion after ischemia.
Putative mechanism of mitochondrial K + flux on mitochondrial protection during IR injury
BKCa and SKCa channel openers appear to have a profound ability to induce PPC but the mechanism is unclear. It is possible that brief ischemia as in IPC causes a slight elevation of mCa 2 + that induces mSKCa and mBKCa channel opening and, like mKATP channel opening, leads to partial dissipation of ∆Ψm and or matrix swelling as a protective mechanism against subsequent IR injury. 57 first suggested that opening mBKCa channels to enhance matrix K + influx is an important factor in mitigating IR injury in a manner similar to mKATP channels. They proposed 57 that the function of mBKCa channels was to improve the efficiency of mitochondrial energy production.
As with the other two K + channels reported in mitochondria, KATP and BKCa, once the K + channel is opened the increase in K + uptake leads to changes in the matrix as described by Garlid et al. and Beavis et al. 77, 78 Electrogenic H + efflux driven by the respiratory chain is balanced by electrophoretic K + influx. If this were uncompensated, it would cause a very large increase in matrix pH of about 2 pH units. Partial compensation is provided by electroneutral uptake of substrate anions, such as phosphate. The compensation is partial because the concentration of phosphate in the cytosol is much lower than that of K + , and this imbalance leads to matrix alkalinization. 79, 80 78 and regulates mitochondrial bioenergetics and ROS emission.
Although mKCa channels likely play a role in regulating mitochondrial bioenergetics, it is unknown how opening of these channels leads to more normalized NADH/FAD levels, reduces excess ROS, and decreases Ca 2 + loading during IR. Just as the existence and function of the mKCa channel in IMM on mitochondrial respiration is unclear, so is the mechanism of K + influx via mKATP channels in IMM. 73, 76, 81, 82, 83, 84 For the KATP channel it was proposed that its opening depolarizes the IMM to cause uncoupling and hasten respiration. 76, 81, 85 Subsequent ischemia would then reduce the driving force for Ca 2 + influx through the mCa 2 + uniporter; this could attenuate mCa 2 + overload 86, 87 so that energized mitochondria on reperfusion would perform more efficiently. Indeed the putative mKATP channel opener diazoxide is reported to reduce the rate of mCa 2 + uptake by depolarizing the IMM and decreasing the driving force for mCa 2 + entry, 76, 81, 85 although this could be due to respiratory inhibition distinct from KATP channel opening. 73, 88 Garlid's group, 73, 88 moreover, proposed that the physiological role of potential mK + channels is control of matrix volume rather than dissipation of ΔΨm and uncoupling. They postulated that matrix swelling by K + uptake is caused by concomitant uptake of Cl − and water by osmosis. But subsequent activation of mKHE may only slightly dissipate the proton gradient (∆μH) by increasing matrix acidity (proton leak) without significantly altering ΔΨm . 74, 88 In turn, mitochondrial swelling might optimize mitochondrial function because partial uncoupling was seen to improve efficiency of oxidative phosphorylation. 89 More specifically, during hypoxia matrix K + influx appears to maintain a normal matrix volume, which preserves a narrow intermembrane space and helps to facilitate energy transfer to ATP-utilizing sites, to reduce outer membrane permeability to nucleotides, and to slow ATP hydrolysis. 73, 74, 75 The end result of mSKCa channel opening, like mKCa channel opening, may be to improve mitochondrial efficiency, reduce m[Ca 2 + ] and ROS production, and thereby to protect overall mitochondrial function during IR.
4.4. Interrelationship and timing of mCa 2 + loading, ∆Ψm, redox state, and ROS during cardiac IR injury Prolonged mitochondrial ischemia is marked by the following: decreasing ∆Ψm, an oxidized redox state, excess ROS, matrix contraction, and increasing mCa 2 + loading. Ca 2 + overload due to leaky IMM could impede normal electron transfer so that greater amounts of ROS are produced during IR. Alternatively, ROS can damage membranes by lipid peroxidation; this can hamper selective permeability to ions and allow cytosolic and mCa 2 + uptake as a result of increased reverse mode sarcolemmal Na + /Ca 2 + exchange (NCE). 90, 91 Our studies in the intact heart model show an interrelationship between O2 − produced, redox state, and mCa 2 + influx during ischemia. Continuously measured NADH and O2 − changed together during ischemia as well as during reperfusion. Ischemia-induced rises in NADH, 4 returned closer to normal values on reperfusion after PPC. These effects were reversed by ROS scavengers or by blocking sarcolemmal KATP and/or mKATP channel opening with GLIB or 5-hydroxydecanoate. 27, 29 Preconditioning also led to reduced ROS generation and improved ATP synthesis in isolated mitochondria. 92 These studies suggest that temporary exposure to distinct cardioprotective drugs before ischemia causes ROS-dependent changes in mitochondrial bioenergetics that initiates a preconditioning effect. mKCa is likely to be activated endogenously as matrix Ca 2 + rises in response to an increase in Ca 2 + load, such as occurs during ischemia; opening these channels pharmacologically before ischemia may lead to added protection.
Summary and limitations
We have furnished ample evidence for the presence of SKCa channels in purified mitochondria and in IMM from cardiac cells, for the functional effects of the IKCa and SKCa channel opener DCEB on K + flux in isolated mitochondria, and for the channel conductance of SKCa proteins incorporated into planar lipid bilayers. Moreover, we have demonstrated that SKCa channel opener DCEB initiates cardiac PPC as shown by marked metabolic and functional improvements during reperfusion. These are supported by better preserved reduced redox state (high NADH and low FAD), decreased O2 − production, reduced mCa 2 + loading during IR, and reduced infarct size. The protection by DCEB was blocked by dismutation of O2 − with TBAP and by the SKCa antagonist NS8593. It is possible that mSKCa channel opening induces a mild proton leak due to mKHE, which accelerates respiration, but maintains ∆Ψm, so that small amounts of generated O2
− trigger a downstream protective pathway.
All of the K + channel agonists may converge on a pathway that stimulates a small amount of ROS. That TBAP blocks protection by this drug and that mitochondria are a major source of ROS, suggest that DCEB exerts its effects primarily in mitochondria. Only relative changes in NADH and FAD levels and ROS formation can be assessed in our model. We did not test if the mSKCa channel is open during IR injury, although we have preliminary evidence that the BKCa channel is open during reperfusion. 93 It is plausible that some factors that induce preconditioning, like small increases in ROS or m[Ca 2 + ], are the same factors, albeit at much greater levels, that cause IR damage. Thus the individual stages of triggering, activation and end-effect must be well delineated to unravel the complicated mechanism underlying the cardiac protection afforded by preconditioning.
